Neogen (NG2) Stock Overview
Develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NG2 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Neogen Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.95 |
| 52 Week High | US$9.80 |
| 52 Week Low | US$4.00 |
| Beta | 1.97 |
| 1 Month Change | 6.00% |
| 3 Month Change | 2.58% |
| 1 Year Change | 97.76% |
| 3 Year Change | -48.71% |
| 5 Year Change | -80.13% |
| Change since IPO | 273.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| NG2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.6% | 2.0% | 2.7% |
| 1Y | 97.8% | -16.2% | 10.2% |
Return vs Industry: NG2 exceeded the German Medical Equipment industry which returned -14.9% over the past year.
Return vs Market: NG2 exceeded the German Market which returned 11.2% over the past year.
Price Volatility
| NG2 volatility | |
|---|---|
| NG2 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 13.7% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: NG2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: NG2's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 2,974 | Mike Nassif | www.neogen.com |
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.
Neogen Corporation Fundamentals Summary
| NG2 fundamental statistics | |
|---|---|
| Market cap | €1.76b |
| Earnings (TTM) | -€516.54m |
| Revenue (TTM) | €738.58m |
Is NG2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NG2 income statement (TTM) | |
|---|---|
| Revenue | US$870.56m |
| Cost of Revenue | US$476.99m |
| Gross Profit | US$393.58m |
| Other Expenses | US$1.00b |
| Earnings | -US$608.84m |
Last Reported Earnings
Feb 28, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.80 |
| Gross Margin | 45.21% |
| Net Profit Margin | -69.94% |
| Debt/Equity Ratio | 37.8% |
How did NG2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/20 23:00 |
| End of Day Share Price | 2026/04/20 00:00 |
| Earnings | 2026/02/28 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Neogen Corporation is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Paul Knight | Brean Capital Historical (Janney Montgomery) |
| Robert Labick | CJS Securities, Inc. |
| David Westenberg | CL King & Associates, Inc. |